CNS disorders are often treated ineffectively by trial-and-error, causing prolonged patient distress and high healthcare costs. Neumarker aims to transform the treatment of CNS disorders through its cutting-edge brain biomarker discovery platform, powered by AI. By identifying predictive brain biomarkers, we can personalize treatment for each patient and accelerate drug development by efficient clinical trials. Neumarker is committed to advancing precision neuromedicine through collaborations with drug developers, clinicians and academic researchers.

Neumarker Inc.

The Palo Alto office focuses on innovation in AI and operational excellence to drive data-driven decision-making.

Neumarker Inc.

Org chart

Teams

Offices

Neumarker Inc.

Org chart

Teams

Offices

Related companies